- Home
- QCLS vs BFRI Comparison
QCLS vs BFRI Comparison
Compare QCLS & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QCLS | BFRI |
|---|---|---|
| Founded | 2014 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.7M | 16.3M |
| IPO Year | 2013 | 2021 |
Fundamental Metrics
Financial Performance| Metric | QCLS | BFRI |
|---|---|---|
| Price | $1.69 | $1.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | 191.4K | ★ 625.4K |
| Earning Date | 04-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 22.33 | ★ 67.70 |
| EPS | N/A | ★ N/A |
| Revenue | $3,929,527.00 | ★ $41,705,000.00 |
| Revenue This Year | N/A | $14.36 |
| Revenue Next Year | N/A | $16.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 32.71 | 11.75 |
| 52 Week Low | $1.76 | $0.57 |
| 52 Week High | $8.17 | $1.66 |
Technical Indicators
Market Signals| Indicator | QCLS | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 23.58 | 55.97 |
| Support Level | N/A | $0.78 |
| Resistance Level | $3.98 | N/A |
| Average True Range (ATR) | 0.18 | 0.10 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 1.73 | 42.81 |
Price Performance
Historical ComparisonAbout QCLS Q/C Technologies Inc.
Q/C Technologies Inc is engaged in building blockchain and cryptocurrency infrastructure that is faster and more energy-efficient through quantum-class laser-based computing. The company uses laser-based processors inspired by quantum technology that can solve complex problems. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.